Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine

小剂量右美托咪定治疗芬太尼过量所致呼吸衰竭

基本信息

  • 批准号:
    10828679
  • 负责人:
  • 金额:
    $ 50.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-20 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

SUMMARY The objective of our proposal is to demonstrate that the restoration of respiratory mechanics and of the metabolism by low doses of the central alpha-2 agonist dexmedetomidine results in an increase in ventilation and prevents the fatal outcome of an opioid overdose. Death by opioid overdose is the consequence of an acute respiratory failure mediated by a direct and indirect inhibition of the medullary respiratory neurons. This inhibition is associated with immediate and prolonged tetanic contractions of the inspiratory and expiratory muscles and an increase in upper-airway resistance that impede respiratory movements for hours. Opioid-induced muscle “rigidity” is produced via neurons in the locus coeruleus and can be suppressed by central alpha-2 agonist agents. Our preliminary results, obtained in sedated and non- sedated rats, show that infusion of low doses of the central alpha-2 agonist dexmedetomidine restores chest wall compliance and suppresses the hypermetabolism produced by fentanyl-induced muscle rigidity, while increasing minute ventilation. The objective of our proposal is to demonstrate that administration of dexmedetomidine, after opioid exposure, prevents a fatal outcome. If efficacy is demonstrated in rodents, we intend to pursue efficacy studies in a non- anesthetized sheep model of fentanyl overdose. This model will allow us to establish the doses of dexmedetomidine needed to produce a beneficial effect without sedation. The effects of intravenous and intranasal dexmedetomidine will be examined. Our intention is to obtain, via 505(b)2 pathway, an FDA approval for non-sedative doses of dexmedetomidine as a treatment of opioid overdose.
总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philippe A Haouzi其他文献

Philippe A Haouzi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philippe A Haouzi', 18)}}的其他基金

Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists
使用 Kappa 激动剂恢复呼吸系统的机械特性来治疗芬太尼过量引起的通气不足
  • 批准号:
    10766378
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists
使用 Kappa 激动剂恢复呼吸系统的机械特性来治疗芬太尼过量引起的通气不足
  • 批准号:
    10410611
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine
小剂量右美托咪定治疗芬太尼过量所致呼吸衰竭
  • 批准号:
    10595421
  • 财政年份:
    2020
  • 资助金额:
    $ 50.09万
  • 项目类别:
Treatment of Fentanyl Overdose-Induced Respiratory Failure by Low-Dose Dexmedetomidine
小剂量右美托咪定治疗芬太尼过量所致呼吸衰竭
  • 批准号:
    10701905
  • 财政年份:
    2020
  • 资助金额:
    $ 50.09万
  • 项目类别:
The cyclic redox dye Azure B as a novel cyanide antidote: in vivo efficacy studies
环状氧化还原染料 Azure B 作为新型氰化物解毒剂:体内功效研究
  • 批准号:
    10223544
  • 财政年份:
    2019
  • 资助金额:
    $ 50.09万
  • 项目类别:
Methylene blue as an antidote against hydrogen sulfide intoxication
亚甲蓝作为硫化氢中毒的解毒剂
  • 批准号:
    9324057
  • 财政年份:
    2016
  • 资助金额:
    $ 50.09万
  • 项目类别:
Methylene blue as an antidote against hydrogen sulfide intoxication
亚甲蓝作为硫化氢中毒的解毒剂
  • 批准号:
    9144894
  • 财政年份:
    2016
  • 资助金额:
    $ 50.09万
  • 项目类别:
Effects of acute administration of the Phenothiazinium Chromophore Methylene blue during life threatening cyanide intoxication
在危及生命的氰化物中毒期间急性施用吩噻嗪发色团亚甲蓝的影响
  • 批准号:
    9357397
  • 财政年份:
    2016
  • 资助金额:
    $ 50.09万
  • 项目类别:
Methylene Blue, A Novel Treatment of H2S Poisoning-induced Brain Injury
亚甲蓝,一种治疗硫化氢中毒脑损伤的新方法
  • 批准号:
    8796074
  • 财政年份:
    2014
  • 资助金额:
    $ 50.09万
  • 项目类别:
Crystalline hydroxocobalamin and methemoglobin as a treatment of H2S intoxication
结晶羟钴胺和高铁血红蛋白治疗 H2S 中毒
  • 批准号:
    8551778
  • 财政年份:
    2012
  • 资助金额:
    $ 50.09万
  • 项目类别:

相似海外基金

Identifying novel molecular targets, signaling pathways and mechanisms underlying fentanyl overdose-induced severe respiratory depression and lethality in rats using TMT phosphoproteomics/proteomics
使用 TMT 磷酸蛋白质组学/蛋白质组学识别芬太尼过量引起大鼠严重呼吸抑制和致死的新分子靶标、信号通路和机制
  • 批准号:
    10831163
  • 财政年份:
    2023
  • 资助金额:
    $ 50.09万
  • 项目类别:
Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose
Sentanyl II:芬太尼/类似物、纳洛酮的多状态分析以及非致命阿片类药物过量的临床特征
  • 批准号:
    10525268
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose
Sentanyl II:芬太尼/类似物、纳洛酮的多状态分析以及非致命阿片类药物过量的临床特征
  • 批准号:
    10904337
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists
使用 Kappa 激动剂恢复呼吸系统的机械特性来治疗芬太尼过量引起的通气不足
  • 批准号:
    10766378
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Sentanyl II: A Multi-State Analysis of Fentanyl/Analogs, Naloxone, and Clinical Features of Non-Fatal Opioid Overdose
Sentanyl II:芬太尼/类似物、纳洛酮的多状态分析以及非致命阿片类药物过量的临床特征
  • 批准号:
    10657719
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Restoring The Mechanical Properties of the Respiratory System as a Treatment of Fentanyl Overdose-Induced Hypoventilation using Kappa Agonists
使用 Kappa 激动剂恢复呼吸系统的机械特性来治疗芬太尼过量引起的通气不足
  • 批准号:
    10410611
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Novel antagonists as fentanyl overdose rescue therapies
作为芬太尼过量救援疗法的新型拮抗剂
  • 批准号:
    10524159
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Novel antagonists as fentanyl overdose rescue therapies
作为芬太尼过量救援疗法的新型拮抗剂
  • 批准号:
    10666669
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials
开发逆转芬太尼及其类似物过量的单克隆抗体:从制造到临床试验
  • 批准号:
    10615519
  • 财政年份:
    2022
  • 资助金额:
    $ 50.09万
  • 项目类别:
I-Corps Project plan for:STTR Phase I Development of therapeutics to treat fentanyl overdose using a validated animal model
I-Corps 项目计划:STTR 第一阶段 使用经过验证的动物模型开发治疗芬太尼过量的疗法
  • 批准号:
    10541304
  • 财政年份:
    2021
  • 资助金额:
    $ 50.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了